Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Certolizumab pegol 200mg/1ml solution for injection cartridges 2 cartridge |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Cimzia 200mg/1ml solution for injection in a dose-dispenser cartridge (UCB Pharma Ltd) |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Benralizumab 30mg/1ml solution for injection pre-filled disposable devices 1 pre-filled disposable injection |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Labetalol 100mg/20ml solution for injection ampoules (Bowmed Ibisqus Ltd) |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Cimzia 200mg/1ml solution for injection in a dose-dispenser cartridge (UCB Pharma Ltd) 2 cartridge |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Fasenra 30mg/1ml solution for injection pre-filled pens (AstraZeneca UK Ltd) |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Labetalol 100mg/20ml solution for injection ampoules (Bowmed Ibisqus Ltd) 5 ampoule |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Fasenra 30mg/1ml solution for injection pre-filled pens (AstraZeneca UK Ltd) 1 pre-filled disposable injection |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Pine mistletoe 10micrograms/ml oral drops |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Apple mistletoe 100micrograms/ml oral drops |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Somatrogon 24mg/1.2ml solution for injection pre-filled disposable devices |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Generic COVID-19 Vaccine Convidecia (Adenovirus Type 5 Vector [recombinant]) 40,000,000,000 viral particles/0.5ml dose solution for injection vials |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Amiodarone 300mg/10ml solution for injection pre-filled syringes (Accord Healthcare Ltd) |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
COVID-19 Vaccine Convidecia (Adenovirus Type 5 Vector [recombinant]) 40,000,000,000 viral particles/0.5ml dose solution for injection vials (CanSino Biologics Inc) 1 dose |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Doxapram 100mg/5ml solution for injection ampoules (Synchrony Pharma Ltd) 5 ampoule |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bupivacaine Heavy 20mg/4ml solution for injection ampoules (Panpharma UK Ltd) 5 ampoule |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
COVID-19 Vaccine Convidecia (Adenovirus Type 5 Vector [recombinant]) 40,000,000,000 viral particles/0.5ml dose solution for injection vials (CanSino Biologics Inc) |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bupivacaine Heavy 20mg/4ml solution for injection ampoules (Panpharma UK Ltd) |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Doxapram 100mg/5ml solution for injection ampoules (Synchrony Pharma Ltd) |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Generic COVID-19 Vaccine Convidecia (Adenovirus Type 5 Vector [recombinant]) 40,000,000,000 viral particles/0.5ml dose solution for injection vials 1 dose |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Amiodarone 300mg/10ml solution for injection pre-filled syringes (Accord Healthcare Ltd) 1 pre-filled disposable injection |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Ketamine 200mg/20ml solution for injection vials (Kent Pharma (UK) Ltd) |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Ketamine 200mg/20ml solution for injection vials 10 vial |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Ketamine 200mg/20ml solution for injection vials (Kent Pharma (UK) Ltd) 10 vial |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Gentamicin 80mg/2ml solution for injection ampoules (Kent Pharma (UK) Ltd) 5 ampoule |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Rocuronium bromide 50mg/5ml solution for injection ampoules (Kent Pharma (UK) Ltd) 10 ampoule |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Rocuronium bromide 50mg/5ml solution for injection ampoules (Kent Pharma (UK) Ltd) |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Gentamicin 80mg/2ml solution for injection ampoules (Kent Pharma (UK) Ltd) |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bupivacaine 25mg/10ml (0.25%) solution for injection ampoules (Kent Pharma (UK) Ltd) 10 ampoule |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Fentanyl 100micrograms/2ml solution for injection ampoules (Kent Pharma (UK) Ltd) 10 ampoule |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bupivacaine 50mg/10ml (0.5%) solution for injection ampoules (Kent Pharma (UK) Ltd) 10 ampoule 10 x blister wrapped ampoules |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Hizentra 1g/5ml solution for injection pre-filled syringes (Imported (United States)) 1 pre-filled disposable injection |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bupivacaine 25mg/10ml (0.25%) solution for injection ampoules (Kent Pharma (UK) Ltd) |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bupivacaine 50mg/10ml (0.5%) solution for injection ampoules (Kent Pharma (UK) Ltd) |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Dexamethasone (base) 6.6mg/2ml solution for injection ampoules (Kent Pharma (UK) Ltd) 10 ampoule |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Water for injections 5ml ampoules (Kent Pharma (UK) Ltd) 20 ampoule |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Dexamethasone (base) 3.3mg/1ml solution for injection ampoules (Kent Pharma (UK) Ltd) 10 ampoule |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bupivacaine 25mg/10ml (0.25%) solution for injection ampoules (Kent Pharma (UK) Ltd) 10 ampoule 10 x blister wrapped ampoules |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bupivacaine 50mg/10ml (0.5%) solution for injection ampoules (Kent Pharma (UK) Ltd) 10 ampoule |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Hizentra 1g/5ml solution for injection pre-filled syringes (Imported (United States)) |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Fentanyl 100micrograms/2ml solution for injection ampoules (Kent Pharma (UK) Ltd) |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Dexamethasone (base) 6.6mg/2ml solution for injection ampoules (Kent Pharma (UK) Ltd) |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Dexamethasone (base) 3.3mg/1ml solution for injection ampoules (Kent Pharma (UK) Ltd) |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Tramadol 100mg/2ml solution for injection ampoules (Milpharm Ltd) |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Tramadol 100mg/2ml solution for injection ampoules (Milpharm Ltd) 5 ampoule |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Ganirelix 250micrograms/0.5ml solution for injection pre-filled syringes (Gedeon Richter (UK) Ltd) |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Ganirelix 250micrograms/0.5ml solution for injection pre-filled syringes (Gedeon Richter (UK) Ltd) 1 pre-filled disposable injection |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Amikacin 500mg/2ml solution for injection vials (Neon Healthcare Ltd) 5 vial |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Amikacin 500mg/2ml solution for injection vials (Neon Healthcare Ltd) |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Magnesium sulfate 50% (magnesium 2mmol/ml) solution for injection 10ml ampoules (Kent Pharma (UK) Ltd) 10 ampoule |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bortezomib 1.8mg/0.72ml in Sodium chloride 0.9% solution for injection pre-filled syringes |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bortezomib 1.6mg/0.64ml in Sodium chloride 0.9% solution for injection pre-filled syringes |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bortezomib 2mg/0.8ml in Sodium chloride 0.9% solution for injection pre-filled syringes |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bortezomib 2.5mg/1ml in Sodium chloride 0.9% solution for injection pre-filled syringes |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bortezomib 2.25mg/0.9ml in Sodium chloride 0.9% solution for injection pre-filled syringes |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bortezomib 2.75mg/1.1ml in Sodium chloride 0.9% solution for injection pre-filled syringes |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bortezomib 3mg/1.2ml in Sodium chloride 0.9% solution for injection pre-filled syringes |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bortezomib 3mg/1.2ml in Sodium chloride 0.9% solution for injection pre-filled syringes (Special Order) |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bortezomib 1.8mg/0.72ml in Sodium chloride 0.9% solution for injection pre-filled syringes 1 pre-filled disposable injection |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Terrosa 20micrograms/80microlitres solution for injection 2.4ml cartridge with pen (Gedeon Richter (UK) Ltd) |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bortezomib 1.6mg/0.64ml in Sodium chloride 0.9% solution for injection pre-filled syringes (Special Order) |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bortezomib 2.75mg/1.1ml in Sodium chloride 0.9% solution for injection pre-filled syringes (Special Order) |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bortezomib 2.5mg/1ml in Sodium chloride 0.9% solution for injection pre-filled syringes (Special Order) |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bortezomib 3mg/1.2ml in Sodium chloride 0.9% solution for injection pre-filled syringes 1 pre-filled disposable injection |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Terrosa 20micrograms/80microlitres solution for injection 2.4ml cartridge (Gedeon Richter (UK) Ltd) 3 cartridge |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bortezomib 2.25mg/0.9ml in Sodium chloride 0.9% solution for injection pre-filled syringes 1 pre-filled disposable injection |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bortezomib 2mg/0.8ml in Sodium chloride 0.9% solution for injection pre-filled syringes (Special Order) |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bortezomib 1.6mg/0.64ml in Sodium chloride 0.9% solution for injection pre-filled syringes 1 pre-filled disposable injection |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Teriparatide 600micrograms/2.4ml solution for injection cartridge 3 cartridge |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bortezomib 2.5mg/1ml in Sodium chloride 0.9% solution for injection pre-filled syringes 1 pre-filled disposable injection |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bortezomib 1.8mg/0.72ml in Sodium chloride 0.9% solution for injection pre-filled syringes (Special Order) 1 pre-filled disposable injection |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Terrosa 20micrograms/80microlitres solution for injection 2.4ml cartridge (Gedeon Richter (UK) Ltd) 1 cartridge |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Terrosa 20micrograms/80microlitres solution for injection 2.4ml cartridge with pen (Gedeon Richter (UK) Ltd) 1 cartridge |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bortezomib 1.8mg/0.72ml in Sodium chloride 0.9% solution for injection pre-filled syringes (Special Order) |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bortezomib 3mg/1.2ml in Sodium chloride 0.9% solution for injection pre-filled syringes (Special Order) 1 pre-filled disposable injection |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bortezomib 2.75mg/1.1ml in Sodium chloride 0.9% solution for injection pre-filled syringes (Special Order) 1 pre-filled disposable injection |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Terrosa 20micrograms/80microlitres solution for injection 2.4ml cartridge (Gedeon Richter (UK) Ltd) |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bortezomib 1.6mg/0.64ml in Sodium chloride 0.9% solution for injection pre-filled syringes (Special Order) 1 pre-filled disposable injection |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bortezomib 2.75mg/1.1ml in Sodium chloride 0.9% solution for injection pre-filled syringes 1 pre-filled disposable injection |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bortezomib 2.25mg/0.9ml in Sodium chloride 0.9% solution for injection pre-filled syringes (Special Order) |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bortezomib 2mg/0.8ml in Sodium chloride 0.9% solution for injection pre-filled syringes 1 pre-filled disposable injection |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bortezomib 2.5mg/1ml in Sodium chloride 0.9% solution for injection pre-filled syringes (Special Order) 1 pre-filled disposable injection |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bortezomib 2mg/0.8ml in Sodium chloride 0.9% solution for injection pre-filled syringes (Special Order) 1 pre-filled disposable injection |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bortezomib 2.25mg/0.9ml in Sodium chloride 0.9% solution for injection pre-filled syringes (Special Order) 1 pre-filled disposable injection |
Has dispensed dose form |
True |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Fosfestrol tetrasodium 60mg/mL injection solution 5mL ampule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Sodium stibogluconate 100mg/mL injection solution 100mL vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Meningococcal C conjugate vaccine injection solution vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Water for injection 10ml ampule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Isoproterenol hydrochloride 1:50,000mg(0.2mg/mL) injection solution 5mL ampule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Anti-D (Rh) immunoglobulin 250iu injection solution vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Calcium chloride 10% injection solution 10mL prefilled syringe |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Meptazinol 100mg/mL injection solution 1mL ampule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Sulfadiazine 1g/4mL injection |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Water for injection 2ml ampule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Water for injection 5ml ampule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Water for injection 1ml ampule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Tetanus immunoglobulin 250iu injection solution vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Ibandronic acid 1mg/mL injection solution 3mL prefilled syringe |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Isoproterenol hydrochloride 1:50,000mg(0.2mg/mL) injection solution 1mL ampule |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Zoledronic acid 5mg injection solution 100mL bottle |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Interferon alfa-2b 10million iu/mL injection solution 2.5mL vial |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|